and semihumid regions of the world (2, 12) . The primary causal agent of scab of wheat in North America, Gibberella zeae (anamorph = Fusarium graminearum), can produce potent toxins, such as the estrogenic toxin zearalenone (8) and the trichothecene deoxynivalenol (DON, vomitoxin) (14, 22) . DON can inhibit amino acid incorporation and protein production in plant tissues (4) , and grain heavily contaminated by the toxin is frequently unsuitable for human consumption and may be refused as feed (27) . Infection of wheat kernels by G. zeae reduces grain yield and affects grain quality (5) . The infection of seed reduces seed germination, seedling vigor, and plant emergence (3) .
Chemical control and resistant cultivars are potential options for reducing the severity of FHB. Registered fungicides can be effective; however, residue and cost concerns are potential problems with chemical usage. All wheat cultivars currently in production are vulnerable to infection. Some success in controlling scab can be achieved by plowing fields after harvest to bury crop residues, but the preference for minimal-tillage agriculture renders this alternative less attractive (6) . Biological control, though currently not available commercially for FHB, would offer another option for reducing the disease (11) . The feasibility of biologically controlling this disease has been demonstrated (9, 13, 24) .
Anthesis is a crucial time for the onset of FHB, with anthers promoting infection of wheat heads by G. zeae (25) . Choline and betaine are found in wheat anthers and are stimulatory to the growth of conidial germ tubes of G. zeae (26) . We surmised that microorganisms isolated from wheat anthers would be a good source of putative biocontrol agents and that information on carbon utilization by anther colonists could prove useful for selecting and formulating biocontrol strains. During our study, highperformance liquid chromatography (HPLC) analysis of culture broths containing individual anther colonists and choline in the form of choline bitartrate identified colonists capable of utilizing tartaric acid but was ineffective in identifying those capable of metabolizing choline. Fortuitously, a higher percentage of tartaric acidutilizing microbes exhibited superior FHB biocontrol capabilities than did nonutilizing microbes. Tartaric acid is a compound that is poorly utilized by G. zeae as a carbon source (D. Schisler, unpublished data) and is a readily available byproduct in the processing of grapes and other fruits for juice and wine (1) .
In previous investigations on biologically controlling plant disease, Schisler and coworkers (19) demonstrated that isolates of a fungal pathogen can differ substantially in their amenability to being suppressed with biocontrol agents. Whether biocontrol strains also vary in their relative effectiveness depending on the isolate of G. zeae used in a bioassay is not known. Additionally, the importance of the order and the timing of arrival of pathogen and biocontrol agent inoculum is not known for this biocontrol system.
Our objectives for this study were to (i) select putative antagonists of G. zeae based on obtaining microbes from anther tissue and assay colonists for their ability to utilize tartaric acid, (ii) screen putative antagonists for their efficacy against G. zeae and determine whether antagonist efficacy depends on pathogen isolate, and (iii) determine if the order or timing of pathogen and biocontrol inoculations impact the suppression of FHB.
MATERIALS AND METHODS
Isolation of anther colonists. In the spring of 1997, anthers were collected from flowering wheat plants across Illinois and Ohio, two states that had experienced recent FHB epidemics. Anthers were removed from wheat flowers using sterilized jeweler's forceps and placed in vials containing 10% (vol/vol) glycerol held at approximately 5°C. Vials then were frozen at -80°C. More than 400 anther collections were obtained. (17) . Suspensions of macroconidia were obtained by flooding the surface of colonized CV8 agar with PO 4 buffer and dislodging conidia using a sterile inoculating loop. At 2 or 3 days before use, microbial strains were recovered from storage in 10% glycerol at -80°C by briefly warming vials at room temperature and streaking partially thawed glycerol onto TSBA/5. Cells were restreaked for purity after 48 h. Biomass of microbial strains was collected by rolling a sterile cotton swab on a 18-to 24-h culture on TSBA/5 and suspending the biomass in PO 4 buffer. Inoculum for wheat heads was prepared that contained antagonist suspension (OD approximately 0.2 to 0.3 at A 620 , 5 × 10 5 conidia/ml and 0.04% [vol/vol] Tween 80; Sigma-Aldrich, St. Louis). To initiate the two-head plant bioassay for antagonists of G. zeae, the middle florets of two heads were coinoculated with 10 µl of a microbial suspension. Heads were inoculated within 2 to 4 days of flowering. Heads inoculated only with conidia of G. zeae served as controls. After inoculation, wheat plants were misted with water, incubated in a plastic humidity chamber for 72 h at approximately 22°C, and transferred to greenhouse benches. Plastic humidity chambers consisted of a PVC pipe frame covered with clear plastic. FHB severity was visually estimated using a 0-to-100% scale (23) 16 days after inoculation. Twenty-six strains, including nine tartaric acid-utilizers, prevented any visible FHB disease development and were selected for second-stage testing of efficacy against G. zeae.
Stage 3 antagonists selection: multiple-head plant bioassay. Management of wheat growth and preparation of G. zeae Z-3639 conidial inoculum were conducted as described above. Biomass of microbial strains was produced in liquid culture. Ten milliliters of semidefined complete liquid medium (20) in 50-ml Erlenmeyer flasks was inoculated to an OD of 0.10 at A 620 with cells grown on TSBA/5 for 24 h. Flasks then were incubated in a shaker incubator at 250 rpm and 25°C for 48 h. At anthesis, 10 µl of an inoculum mixture of G. zeae (5 × 10 5 conidia/ml) and cells of a putative antagonist (48-h colonized broth diluted to 25% with PO 4 buffer; approximately 2 × 10 9 and 5 × 10 8 CFU/ml for bacteria and yeast strains, respectively) were used to inoculate single florets on 16 wheat heads (4 heads per replication, four replications/treatment). Plants were scored for disease severity after 16 days. Of the 26 strains assayed, 7 reduced FHB severity by 25 to 80% (P ≤ 0.10, data not shown) and were selected for further studies. Antagonist bioassay against G. zeae isolates of different origin. Multiple-head plant bioassays were conducted as described above using the seven antagonists selected. Isolates of G. zeae used in the bioassays were Z3639, DAOM 180378, and Fg-9-96, originally isolated from Kansas, Ontario (Canada), and Ohio, respectively. Heads inoculated only with G. zeae conidia or only with PO 4 buffer served as controls. Disease severity was rated as described above and 100-kernel weight was determined after harvest. G. zeae was recovered via plating symptomatic tissue from randomly selected heads onto CV8 medium. There were four heads per replication and four replications per treatment distributed in a completely randomized design. Experiments with each isolate of G. zeae were performed at least twice. Data from repeated experiments were pooled because statistical analysis demonstrated that experiment interactions were rarely significant. Disease severity data were normalized when needed using the arcsine transformation before analysis of variance (ANOVA). Means were separated at P ≤ 0.05 using Fisher's protected least significance difference test (PC SAS, ver. 6.12; SAS Institute, Inc., Cary, NC). Relative performance indices of efficacy (RPI efficacy ) were calculated for each antagonist performance against each isolate of G. zeae. For each experiment, an RPI efficacy value was calculated for each replication of each antagonist treatment. These values were used to calculate an average RPI efficacy for each antagonist strain and for ANOVA and mean separation of antagonist RPI efficacy averages. Relative performance indices allow different types of data to be compared using a standard scale and are dimensionless values that will theoretically range from 0 to 100, in which 100 = maximum antagonist efficacy relative to the other antagonist strains tested. Assuming FHB severity ratings are normally distributed, Z (the standard normal variate) will range from -2 to +2 (95% probability) when Z = (X -»)/s, where X is a single disease rating value observed for an antagonist strain, and » and s are the average and standard deviation, respectively, of all values obtained for all antagonist strains (21) . RPI efficacy then is calculated as:(Z -2) × 25. For data sets where some Z values fall outside the range of -2 to +2, RPI efficacy is more accurately calculated as (2 -Z) × 25.
Influence of order and timing of inoculum application on FHB disease. Management of wheat growth, microbial biomass preparation in liquid culture, and G. zeae conidial inoculum preparation were conducted as described above. A spray inoculation method was used to mimic the arrival of inoculum at the infection court in the field. An aqueous suspension (2 ml) containing G. zeae isolate Z3639 at 5 × 10 5 conidia/ml and 0.04% Tween 80 was applied as a mist (Spr• Tool; North American Professional Products, Woodstock, IL) over four wheat heads, immediately before or after and 4 h before or after treating heads with 5 ml of an aqueous suspension containing antagonist cells. Antagonist cells were applied at 10 or 50% of 48-h colonized broth. Heads sprayed only with conidia of G. zeae served as controls. Treatments were distributed in a completely randomized design (n = 4). Experiments were performed at least twice. Data analysis was as described above for separating treatment means from controls. Orthogonal contrasts provided analysis of the effect of antagonist concentration on FHB severity.
RESULTS
Antagonist selection. Approximately 7% (54 strains) of the strains recovered from anthers utilized tartaric acid in liquid culture. Tartaric acid-utilizers and an additional 188 randomly selected strains were used in replicated greenhouse plant bioassays to determine strain efficacy in reducing FHB. Twenty-six strains, including eight tartaric acid-utilizers, prevented the development of any visible FHB symptoms in two-head plant bioassays. Of the 26 strains tested (Table 1) , 7, including 4 tartaric acid-utilizers, were superior in significantly reducing FHB disease in multiple-head plant bioassays (P ≤ 0.10, data not shown). A higher proportion of tartaric acid-utilizing strains (4 of 54) were superior biocontrol strains than were nonutilizers (3 of 188) (P ≤ 0.05, χ-square test of goodness of fit). None of the seven strains utilized choline in liquid culture (N. Khan, unpublished data).
Antagonist bioassay against G. zeae isolates of different origin. Bacillus strains AS 43.3 and AS 43.4, and Cryptococcus strain OH 182.9 (Table 1) reduced FHB disease severity by 77, 93, and 56%, respectively, in assays against G. zeae isolate Z3639 (P ≤ 0.05, Table 2 ). All seven antagonists reduced FHB as indicated by increased 100-kernel weight of microbially treated wheat heads (P ≤ 0.05, Table 2 ). Treatments with antagonist strains AS 43.3, AS 43.4, and OH 182.9 increased 100-kernel weight by 140, 144, and 100%, respectively. In bioassays against isolate DAOM 180378 of G. zeae, only strains AS 43.3 and AS 43.4 reduced disease as measured by either reduction in disease severity or disease incidence. Five strains increased 100-kernel weight, whereas Cryptococcus sp. OH 181.1 decreased 100-kernel weight (Table 2) . Conversely, in bioassays using isolate Fg-9-96 of G. zeae, all antagonists except yeast OH 72.4 increased 100-kernel weight and four of seven antagonists reduced disease severity (P ≤ 0.05, Table 2 ). Overall, strains AS 43.3 and AS 43.4 consistently reduced FHB disease regardless of the isolate of G. zeae used in the bioassays (Table 2) . Cryptococcus spp. OH 71.4 and OH 182.9 reduced disease caused by all three isolates of G. zeae as quantified by at least one of the disease parameters measured. The remaining three antagonists were effective against two of the three isolates of G. zeae tested. Antagonist rankings based on RPI efficacy varied depending on the isolate of G. zeae (Table 3) . Significant differences in the RPI efficacy values obtained for antagonist strains AS 43.4, The middle floret of a central spikelet of a wheat head was coinoculated with 10 µl of a 48-h antagonist-colonized broth diluted to 25% with PO 4 buffer (10 8 to 10 9 CFU/ml) and G. zeae conidia (5 × 10 5 conidia/ml). z DS = disease severity, DI = disease incidence, 100-kw = 100-kernel weight, NT = not tested. Within a column, means followed by an asterisk are significantly different from the G. zeae control (Fisher's protected least significant difference, P ≤ 0.05).
OH 71.4, and OH 182.9 when assayed against the three isolates of G. zeae indicated that the relative efficacy of these antagonist strains was dependent on the pathogen isolate used to incite disease. Influence of order and timing of inoculum application on FHB disease. In spray-inoculation experiments, all antagonists significantly reduced disease severity, regardless of the sequence, timing, and concentration of inoculum application (P ≤ 0.05, Table 4 ), though some antagonists did not increase 100-kernel weight when inoculum of G. zeae was applied 4 h before the antagonist (Table 5 ). The comparison of antagonist concentration response as measured by orthogonal contrasts for disease severity indicated no significant effect of concentration for all the antagonists except AS 43.4 when G. zeae inoculum was applied 4 h before the antagonist (Table 6 ). When pathogen inoculum was applied immediately before or after antagonists, antagonist concentration influenced disease severity in some cases, though higher antagonist concentration was not consistently associated with greater reduction in disease severity (Table 6 ). All antagonists showed some significant differences in concentration effect on 100-kernel weight (Table 7) , although increased antagonist concentration was not always associated with increased efficacy in reducing FHB disease. Bacillus strains were generally more effective in reducing FHB severity than were yeast isolates (P ≤ 0.05, data not shown). Bacillus strains decreased FHB severity irrespective of their method of application on the wheat head (i.e., whether applied as a spray mist or via inoculation of single wheat florets). However, yeasts were more effective in suppressing FHB severity when applied as a mist than when applied to single florets (Tables 2, 4 , and 5).
DISCUSSION
Selection of putative antagonists for biological control of plant diseases usually involves collecting and screening large numbers of microbial isolates to enhance the probability of discovering a highly effective strain. Screening a large number of putative antagonists through the laborintensive technique of plant bioassay may not be a feasible strategy for the initial selection of candidate antagonists if plant material is difficult to manipulate or produce. Therefore, various tests for the preselection of putative antagonists and the narrowing of the number of antagonists for bioassay on plants have been attempted, including in vitro antibiosis tests conducted on nutrient agar. However, the test medium used in these assays can influence the degree of antibiosis shown by putative antagonists (7, 18) . Additionally, the correlation between in vitro antibiosis on agar medium and biological control in situ is frequently inconsistent (10, 15) .
From a collection of 738 microorganisms obtained from wheat anthers, we selected 54 microbial strains that utilized tartaric acid and 188 that did not. As a relatively inexpensive byproduct from the production of grape and other fruit juices (1), tartaric acid has potential for use in formulations of tartaric acid-utilizing antagonists because the compound is poorly utilized by G. zeae (D. A. Schisler, unpublished data). Of 54 tartaric acid-utilizing isolates, 4 (7.4%) consistently reduced FHB disease severity and increased 100-kernel weights. In contrast, only 3 of 188 microbial isolates (1.6%) that did not utilize tartaric acid were successful in reducing FHB. This reduction in disease was obtained using microbial biomass produced in a liquid culture medium that should be affordable for use on a commercial scale. Testing candidate microbes for their ability to utilize tartaric acid may be a useful preliminary screen for narrowing the search for FHB antagonists. Employing this screening method substantially reduced the number of strains that advanced to the labor-intensive step of plant testing, yet provided a high percentage of those strains that were effective. Though tartaric acid is present in many fruits, we are not aware of any reports of its presence in wheat tissues. We are currently investigating this possibility. Choline is present in wheat anthers and stimulates early germ tube growth of G. zeae (26) . Surprisingly, none of the top FHB antagonists identified in this study utilized choline in liquid culture, though recently discovered strains with potential to biologically control FHB do (N. Khan, unpublished data). The preliminary screening of putative antagonists also included recovering isolates from anthers on Solulys medium, a medium composed of relatively inexpensive nutrient sources that could be economically feasible for use in commercial production of microbial biomass. Additionally, biomass of putative antagonists was produced in liquid culture early in the selection process. Production of antagonists in liquid versus solid media and in liquid media of differing composition can affect the relative and overall performance of the antagonists produced (19) . Even during the early stages of antagonist selection, therefore, antagonist biomass should be produced using a medium feasible for use in commercial production.
All seven of the antagonists chosen from the multiple-head plant bioassays reduced FHB disease symptoms incited by two of the three isolates of G. zeae, and four of the strains reduced symptoms incited by all three isolates of G. zeae. Interestingly, pathogen isolate influenced the relative efficacy of antagonist strains AS 43.4, OH 71.4, and OH 182.9 as determined by RPI efficacy values. It is not known whether this indicates that these strains will be more variable in performance than the other antagonists when tested in field environments where a diversity of G. zeae genotypes would be encountered. Differences in relative performance between potato dry rot antagonists when tested against a variety of isolates of G. pulicaris also have been reported (19) .
Bacillus strains AS 43.3 and AS 43.4 consistently decreased FHB disease severity, increased 100-kernel weight, or both, regardless of the method of antagonist application utilized. Although determining the mode of action of antagonists was not part of this study, antibiosis may be a mechanism of biological control for strains AS 43.3 and AS 43.4 because they inhibited the growth of G. zeae in petri plate antagonism tests (N. Khan, unpublished data). The yeast isolates in this study did not demonstrate petri plate antagonism of G. zeae but were all utilizers of tartaric acid. Interestingly, all of the yeast isolates were more successful in reducing the severity of FHB when applied as a mist compared with when inoculated at a single point on a wheat head. This may be due to the fact that, in point inoculation, pathogen inoculum is placed within a floret, thereby directly providing an infection court to the pathogen and limiting the opportunity for yeasts to compete with G. zeae for nutrients before the pathogen has successfully invaded the host tissue. On the other hand, when sprayed on the external surfaces of the wheat head along with pathogen inoculum, yeasts may have an increased opportunity to compete for the nutrients present at the infection court, especially on anthers (25) .
Although these antagonist strains were effective against three different isolates of G. zeae that were collected from three widely separated locations, it has yet to be seen how they will perform in field trials at different locations. Work will also be needed to enhance formulation technologies, including identifying additional compounds that could be used to preferentially enhance the activity of the biocontrol agents. In the absence of highly resistant cultivars or highly effective registered fungicides, this study confirms the potential of biological control as a viable option in an integrated pest management program for reducing scab of wheat. 
